4.2 Letter

Is CD56 a specific and reliable neuroendocrine marker for discriminating between endocrine/neuroendocrine ductal carcinoma in situ and intraductal papilloma of the breast?

Journal

PATHOLOGY INTERNATIONAL
Volume 61, Issue 1, Pages 49-51

Publisher

WILEY
DOI: 10.1111/j.1440-1827.2010.02604.x

Keywords

-

Categories

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available